Clinical Trials on Healthy Volunteers, Gluten

Total 20490 results

Alpine Immune Sciences, Inc.

Completed

A Study of ALPN-303 in Adult Healthy Volunteers (RUBY-1)

Healthy Volunteers

Australia
Trinomab Biotech Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults

Healthy Volunteers

China
Syneos Health
Otsuka Pharmaceutical Development & Commercialization, Inc.

Terminated

To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects

Healthy Volunteers

Australia
Silence Therapeutics plc

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Hoffmann-La Roche

Completed

A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous Administration In Healthy Participants

Healthy Volunteers

United States
Société des Produits Nestlé (SPN)

Terminated

Tolerance and Safety of an Oral Nutritional Supplement (Glaze)

Healthy Volunteers

Switzerland
Nuance Pharma (shanghai) Co., Ltd

Completed

A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects

Healthy Volunteers

China
Manchester University NHS Foundation Trust

Completed

Normative Cardiovascular Magnetic Resonance Values for Measurement of Cardiovascular Structure and Function at MCMR (NORMAL MCMR)

Healthy Volunteers

United Kingdom
Insmed Incorporated

Completed

A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants

Healthy Volunteers

United States
Chong Kun Dang Pharmaceutical

Completed

A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects

Healthy Volunteers

United States
Global Antibiotics Research and Development Partnership
Parexel; KCAS

Completed

Zoliflodacin Bioequivalence and Drug-Drug Interaction Study

Healthy Volunteers

Germany
University Hospital, Grenoble
GIPSA-LAB; Clinical Investigation Centre for Innovative Technology Network

Completed

Detection of Early Swallowing Time by Electromyogram and Sound Recording in Healthy Volunteers (DEGLUTITION)

Healthy Volunteers

France
Bristol-Myers Squibb

Completed

A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulation, the Effect of Food on the Bioavailability of Branebrutinib From a Tablet Formulation, and the Safety and Drug Levels of Branebrutinib From a Tablet Formulation in Healthy Participants

Healthy Volunteers

United States
SIMR (Australia) Biotech Pty Ltd.

Completed

The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers

Healthy Volunteers

Australia
Bristol-Myers Squibb

Completed

A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants

Healthy Volunteers

United States
Prestige Biopharma Limited

Completed

To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects

Healthy Volunteers

New Zealand
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

Healthy Volunteers

Korea, Republic of
GlaxoSmithKline

Completed

A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants

Healthy Volunteers

United States
Abivax S.A.

Completed

Safety and Pharmacokinetics Study in Healthy Japanese Volunteers

Healthy Volunteers

Japan
Origo Biopharma

Completed

First in Human Study of ORG-129 in Healthy Volunteers

Healthy Volunteers

Spain
AbbVie

Completed

A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor (M23-492 FE)

Healthy Volunteers

United States
BioVersys SAS
Nuvisan GmbH

Completed

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects

Healthy Volunteers

Germany
Bristol-Myers Squibb

Completed

A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants

Healthy Volunteers

United States
Haisco Pharmaceutical Group Co., Ltd.

Completed

Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers

Healthy Volunteers

China
BeiGene

Withdrawn

Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

Healthy Volunteers

United States
TYK Medicines, Inc

Completed

A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers

Healthy Volunteers

China
Bristol-Myers Squibb

Completed

A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants

Healthy Volunteers

United States
Takeda

Withdrawn

A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval

Healthy Volunteers
Eisai Limited

Suspended

A Study to Evaluate the Relative Bioavailability of E7386 Following Oral Administration of Targeted Release (TR) Tablets Compared to an E7386 Immediate Release (IR) Tablet in Healthy Adult Participants

Healthy Volunteers

United Kingdom
XWPharma

Completed

Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults

Healthy Volunteers

Australia
University of Vigo
Colexio Oficial de Fisioterapeutas de Galicia

Completed

Effects of Taping on the Proprioceptive System

Healthy Volunteers

Spain
Seoul National University Hospital

Completed

Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers (CYP_IVPO)

Healthy Volunteers

Korea, Republic of
IGM Biosciences, Inc.

Terminated

Evaluation of IGM-6268 in Healthy Volunteers

Healthy Volunteers

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

Assessment of New Magnetic Resonance Imaging (MRI) Pulse Sequences for Imaging Hyperpolarised Xenon in Lung, Heart and Brain in Volunteers

Healthy Volunteers

United Kingdom
Novartis Pharmaceuticals

Completed

A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers (MAS-FIH)

Healthy Volunteers

United States, United Kingdom
Amgen

Completed

Safety Study of Tezepelumab (AMG 157) in Healthy Adults

Healthy Volunteers
Eisai Inc.

Completed

A Study to Assess the Safety and Tolerability of E2511 in Healthy Adult and Elderly Participants

Healthy Volunteers

United States
Orion Corporation, Orion Pharma

Completed

Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler (TEMPO)

Healthy Volunteers

Finland
Takeda

Completed

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants

Healthy Volunteers

United States
Cortexyme Inc.

Completed

A Single and Multiple Ascending Dose Study of COR588

Healthy Volunteers

Australia
University Hospital, Tours

Completed

Brain Changes in EEG and Brain Pulsatility to Novel Stimuli (Electro-PulCe) (Electro-Pulce)

Healthy Volunteers

France
Atridia Pty Ltd.

Completed

A Trial of SHR-1819 in Healthy Subjects

Healthy Volunteers

Australia
H. Lundbeck A/S

Terminated

Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants

Healthy Volunteers

Japan
Dizal Pharmaceuticals

Completed

A Study of DZD2269 in Healthy Adult Participants

Healthy Volunteers

United States
Venatorx Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Terminated

VNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers

Healthy Volunteers

New Zealand
Astellas Pharma Inc

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants

Healthy Volunteers

Japan
Astellas Pharma Global Development, Inc.

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect

Healthy Volunteers

United States
Dizal Pharmaceuticals

Completed

Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants

Healthy Volunteers

United States
Bristol-Myers Squibb

Completed

Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants

Healthy Volunteers

United States
SP Nutraceuticals Inc.
Canadian Glycomics Network (GlycoNet)

Completed

Safety Evaluation of β-arbutin in Healthy Human Subjects

Healthy Volunteers

Canada

3

Subscribe